Suppr超能文献

采用液相色谱联用LTQ Orbitrap质谱仪对用于治疗银屑病的中药配方PSORI-CM01进行鉴定和定量表征。

Identification and quantitative characterization of PSORI-CM01, a Chinese medicine formula for psoriasis therapy, by liquid chromatography coupled with an LTQ Orbitrap mass spectrometer.

作者信息

Chen Shao-Dan, Lu Chuan-Jian, Zhao Rui-Zhi

机构信息

The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510000, China.

出版信息

Molecules. 2015 Jan 19;20(1):1594-609. doi: 10.3390/molecules20011594.

Abstract

PSORI-CM01 is a Chinese medicine formula prepared from medicinal herbs and used in China for the treatment of psoriasis. However, the chemical constituents in PSORI-CM01 have not been clarified yet. In order to quickly define the chemical profiles and control the quality of PSORI-CM01 preparations, ultra-high liquid chromatography coupled with electrospray ionization hybrid linear trap quadrupole Orbitrap mass spectrometry (UHPLC-ESI-LTQ/Orbitrap-MS) was applied for simultaneous identification and quantification of multiple constituents. A total of 108 compounds, including organic acids, phenolic acids, flavonoids, and terpenoids, were identified or tentatively deduced on the base of their retention behaviors, MS and MSn data, or by comparing with reference substances and literature data. In addition, an optimized UHPLC-ESI-MS method was established for the quantitative determination of 14 marker compounds in different dosage forms of PSORI-CM01 preparations. The validation of the method, including spike recoveries, linearity, sensitivity (LOQ), precision, and repeatability, was carried out and demonstrated to be satisfied the requirements of quantitative analysis. This is the first report on the comprehensive determination of chemical constituents in PSORI-CM01 preparations by UHPLC-ESI-LTQ/Orbitrap mass spectrometry. The results suggested that the established methods would be a powerful and reliable analytical tool for the characterization of multi-constituents in complex chemical system and quality control of TCM preparations.

摘要

PSORI-CM01是一种由草药制成的中药配方,在中国用于治疗银屑病。然而,PSORI-CM01中的化学成分尚未明确。为了快速确定PSORI-CM01制剂的化学特征并控制其质量,采用超高效液相色谱-电喷雾电离混合线性阱四极杆轨道阱质谱联用技术(UHPLC-ESI-LTQ/Orbitrap-MS)对多种成分进行同时鉴定和定量分析。基于保留行为、质谱和多级质谱数据,或通过与对照品及文献数据比较,共鉴定或初步推断出108种化合物,包括有机酸、酚酸、黄酮类化合物和萜类化合物。此外,建立了一种优化的UHPLC-ESI-MS方法,用于定量测定PSORI-CM01制剂不同剂型中的14种标志性化合物。对该方法进行了加样回收率、线性、灵敏度(定量限)、精密度和重复性等验证,结果表明该方法满足定量分析要求。这是首次报道采用UHPLC-ESI-LTQ/Orbitrap质谱联用技术对PSORI-CM01制剂中的化学成分进行全面测定。结果表明,所建立的方法将是一种用于复杂化学体系中多成分表征及中药制剂质量控制的强大而可靠的分析工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bca5/6272627/9ffb62f3c886/molecules-20-01594-g001.jpg

相似文献

4
Formula PSORI-CM01 eliminates psoriasis by inhibiting the expression of keratinocyte cyclin B2.
BMC Complement Altern Med. 2016 Jul 29;16:255. doi: 10.1186/s12906-016-1234-6.
6
Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression.
Int Immunopharmacol. 2017 Mar;44:226-233. doi: 10.1016/j.intimp.2017.01.023. Epub 2017 Jan 25.
8
Analysis of Chemical Constituents in Wuzi-Yanzong-Wan by UPLC-ESI-LTQ-Orbitrap-MS.
Molecules. 2015 Dec 1;20(12):21373-404. doi: 10.3390/molecules201219765.
10
Molecular mechanism of PSORI-CM01 for psoriasis by regulating the inflammatory cytokines network.
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116935. doi: 10.1016/j.jep.2023.116935. Epub 2023 Jul 20.

引用本文的文献

1
MicroRNA-31 mediated inhibition of keratin 6 by PSORI-CM01: a novel approach to psoriasis amelioration.
Front Chem. 2025 Jul 18;13:1636529. doi: 10.3389/fchem.2025.1636529. eCollection 2025.
2
Efficacy of Aster chinensis aerial parts metabolites in BALB/c mice model of Imiquimod-induced psoriasis skin inflammation.
Inflammopharmacology. 2025 Apr;33(4):1973-1996. doi: 10.1007/s10787-025-01652-x. Epub 2025 Mar 12.
4
Potential Mechanisms of Imidacloprid-Induced Neurotoxicity in Adult Rats with Attempts on Protection Using L. Oil/Extract: and Studies.
ACS Omega. 2023 May 17;8(21):18491-18508. doi: 10.1021/acsomega.2c08295. eCollection 2023 May 30.
8
Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson's Disease through the Inflammation Pathway.
Evid Based Complement Alternat Med. 2019 Dec 21;2019:2529641. doi: 10.1155/2019/2529641. eCollection 2019.
9
Curative Anti-Inflammatory Properties of Chinese Optimized Yinxieling Formula in Models of Parkinson's Disease.
Evid Based Complement Alternat Med. 2018 Nov 4;2018:6142065. doi: 10.1155/2018/6142065. eCollection 2018.
10

本文引用的文献

7
Diarylheptanoids from the Rhizomes of Curcuma kwangsiensis.
J Nat Prod. 2010 Oct 22;73(10):1667-71. doi: 10.1021/np100392m. Epub 2010 Sep 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验